TREATMENT MAY EASE CANCER-RELATED BONE PAIN
Treatment with the investigational drug Xinlay may help ease the bone pain that often accompanies late-stage cancer, researchers say. Dr. Nicholas Vogelzang of the Nevada Cancer Institute told a meeting of American Society of Clinical Oncology much of the recent focus on prostate cancer has centered on detection and prevention, and little attention has been paid to improving quality of life for patients in advanced stages of the disease, exemplified by the late actor Jerry Orbach. During this phase of disease, the body no longer responds to hormone therapy and the cancer spreads to the bone resulting in excruciating pain. More than 85 percent of men with late-stage prostate cancer develop bone metastases. As the bones are replaced with tumor, surrounding nerve endings are continuously irritated and send pain signals to the brain. Studies suggest Xinlay may help delay disease progression and decrease the onset and incidence of such pain.
For more information, contact Meredith Klein at 312-751-4197